The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way.
The global 3D Printed Drugs market was valued at US$ 224.3 million in 2023 and is anticipated to reach US$ 297.8 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for 3D Printed Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printed Drugs.
Report Scope
The 3D Printed Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 3D Printed Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Printed Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Aprecia Pharmaceuticals
- GlaxoSmithKline
- Revolution Medicines
- FabRX
Segment by Type
- Spritam
- Others
Segment by Application
- Children
- Elderly
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 3D Printed Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 3D Printed Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 3D Printed Drugs Market Overview
1.1 Product Overview and Scope of 3D Printed Drugs
1.2 3D Printed Drugs Segment by Type
1.2.1 Global 3D Printed Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Spritam
1.2.3 Others
1.3 3D Printed Drugs Segment by Application
1.3.1 Global 3D Printed Drugs Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Elderly
1.3.4 Others
1.4 Global 3D Printed Drugs Market Size Estimates and Forecasts
1.4.1 Global 3D Printed Drugs Revenue 2019-2030
1.4.2 Global 3D Printed Drugs Sales 2019-2030
1.4.3 Global 3D Printed Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 3D Printed Drugs Market Competition by Manufacturers
2.1 Global 3D Printed Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global 3D Printed Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global 3D Printed Drugs Average Price by Manufacturers (2019-2024)
2.4 Global 3D Printed Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 3D Printed Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 3D Printed Drugs, Product Type & Application
2.7 3D Printed Drugs Market Competitive Situation and Trends
2.7.1 3D Printed Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 3D Printed Drugs Players Market Share by Revenue
2.7.3 Global 3D Printed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 3D Printed Drugs Retrospective Market Scenario by Region
3.1 Global 3D Printed Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global 3D Printed Drugs Global 3D Printed Drugs Sales by Region: 2019-2030
3.2.1 Global 3D Printed Drugs Sales by Region: 2019-2024
3.2.2 Global 3D Printed Drugs Sales by Region: 2025-2030
3.3 Global 3D Printed Drugs Global 3D Printed Drugs Revenue by Region: 2019-2030
3.3.1 Global 3D Printed Drugs Revenue by Region: 2019-2024
3.3.2 Global 3D Printed Drugs Revenue by Region: 2025-2030
3.4 North America 3D Printed Drugs Market Facts & Figures by Country
3.4.1 North America 3D Printed Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America 3D Printed Drugs Sales by Country (2019-2030)
3.4.3 North America 3D Printed Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe 3D Printed Drugs Market Facts & Figures by Country
3.5.1 Europe 3D Printed Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe 3D Printed Drugs Sales by Country (2019-2030)
3.5.3 Europe 3D Printed Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 3D Printed Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific 3D Printed Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific 3D Printed Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific 3D Printed Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America 3D Printed Drugs Market Facts & Figures by Country
3.7.1 Latin America 3D Printed Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America 3D Printed Drugs Sales by Country (2019-2030)
3.7.3 Latin America 3D Printed Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 3D Printed Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa 3D Printed Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa 3D Printed Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa 3D Printed Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global 3D Printed Drugs Sales by Type (2019-2030)
4.1.1 Global 3D Printed Drugs Sales by Type (2019-2024)
4.1.2 Global 3D Printed Drugs Sales by Type (2025-2030)
4.1.3 Global 3D Printed Drugs Sales Market Share by Type (2019-2030)
4.2 Global 3D Printed Drugs Revenue by Type (2019-2030)
4.2.1 Global 3D Printed Drugs Revenue by Type (2019-2024)
4.2.2 Global 3D Printed Drugs Revenue by Type (2025-2030)
4.2.3 Global 3D Printed Drugs Revenue Market Share by Type (2019-2030)
4.3 Global 3D Printed Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global 3D Printed Drugs Sales by Application (2019-2030)
5.1.1 Global 3D Printed Drugs Sales by Application (2019-2024)
5.1.2 Global 3D Printed Drugs Sales by Application (2025-2030)
5.1.3 Global 3D Printed Drugs Sales Market Share by Application (2019-2030)
5.2 Global 3D Printed Drugs Revenue by Application (2019-2030)
5.2.1 Global 3D Printed Drugs Revenue by Application (2019-2024)
5.2.2 Global 3D Printed Drugs Revenue by Application (2025-2030)
5.2.3 Global 3D Printed Drugs Revenue Market Share by Application (2019-2030)
5.3 Global 3D Printed Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aprecia Pharmaceuticals
6.1.1 Aprecia Pharmaceuticals Corporation Information
6.1.2 Aprecia Pharmaceuticals Description and Business Overview
6.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Product Portfolio
6.1.5 Aprecia Pharmaceuticals Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline 3D Printed Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline 3D Printed Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Revolution Medicines
6.3.1 Revolution Medicines Corporation Information
6.3.2 Revolution Medicines Description and Business Overview
6.3.3 Revolution Medicines 3D Printed Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Revolution Medicines 3D Printed Drugs Product Portfolio
6.3.5 Revolution Medicines Recent Developments/Updates
6.4 FabRX
6.4.1 FabRX Corporation Information
6.4.2 FabRX Description and Business Overview
6.4.3 FabRX 3D Printed Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FabRX 3D Printed Drugs Product Portfolio
6.4.5 FabRX Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 3D Printed Drugs Industry Chain Analysis
7.2 3D Printed Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 3D Printed Drugs Production Mode & Process
7.4 3D Printed Drugs Sales and Marketing
7.4.1 3D Printed Drugs Sales Channels
7.4.2 3D Printed Drugs Distributors
7.5 3D Printed Drugs Customers
8 3D Printed Drugs Market Dynamics
8.1 3D Printed Drugs Industry Trends
8.2 3D Printed Drugs Market Drivers
8.3 3D Printed Drugs Market Challenges
8.4 3D Printed Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
